My theory is that full immunity is achieved only b

My theory is that full immunity is achieved only by a homozygous double mutant just the same as HIV.

The Brazil study earlier in this thread suggests the natural covid immunity reduces the frequency of heterozygous mutants found in a trial to roughly half of the frequency in the general population.

In the Brazil study, 10% of the covid sick patients were heterozygous.

So 10% times CD12's 394 yields about 40 heterozygotes in CD12.

But maybe Cdiddy is right, the natural immunity of heterozygotes is even better and its only 20 or 10 or 5 heterozygotes in the CD12 trial.

But lower numbers of heterozygotes in CD12 is not a discouragement for genotyping, its a massive encouragement because it suggests that maybe if the RO is high enough then the natural immunity is recapitulated by leronlimab.

If I genotype covid patients and I find fewer CCR5delta32 than I expect then I am encouraged to look very hard, and very quickly, at ways to increase the RO by increasing the dose and going intravenous.